Plus Therapeutics (PSTV) Stock Chart & Stock Price History → How’d you do in 2022 (From Brooks Enterprises) (Ad) Free PSTV Stock Alerts $2.30 +0.05 (+2.22%) (As of 10:40 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Plus Therapeutics Stock Price Performance5 Day Performance+6.98%1 Month Performance+27.78%3 Month Performance+7.98%6 Month Performance+14.43%Year-To-Date Performance+31.42%1 Year Performance-41.48% Receive PSTV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThe only AI company to buyMusk originally co-founded OpenAI with Sam Altman back in 2015. But after a series of disagreements, Musk left the company in 2018. And while Musk and Altman continue to fight it out for the future of artificial intelligence, including a bitter lawsuit… There is one key area they both agree on – a critical technology I call “The AI Keystone.”You must read this new presentation from Porter Stansberry. PSTV Stock Chart for Tuesday, June, 4, 2024 PSTV Chart by TradingView Plus Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/03/2024$2.21$2.25+1.81%$2.25$2.1647,040 shs$12.83 million05/31/2024$2.15$2.21+2.79%$2.25$2.1044,052 shs$12.60 million05/30/2024$2.12$2.15+1.42%$2.18$2.0518,244 shs$12.26 million05/29/2024$2.15$2.12-1.40%$2.24$2.0912,902 shs$12.09 million05/28/2024$2.14$2.15+0.47%$2.26$2.1013,514 shs$12.26 million05/27/2024$2.14$2.14$2.16$2.067,900 shs$12.20 million Get the Latest News and Ratings for PSTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/24/2024$2.16$2.14-0.93%$2.16$2.067,988 shs$12.21 million05/23/2024$2.18$2.16-0.92%$2.18$2.0917,905 shs$12.31 million05/22/2024$2.13$2.18+2.35%$2.19$2.118,629 shs$12.43 million05/21/2024$2.18$2.13-2.29%$2.19$2.0440,464 shs$12.14 million05/20/2024$2.24$2.18-2.68%$2.25$2.1530,382 shs$12.43 million05/17/2024$2.25$2.24-0.44%$2.32$2.1240,977 shs$9.59 million05/16/2024$2.32$2.25-3.02%$2.30$2.1840,826 shs$9.63 million05/15/2024$2.17$2.32+6.91%$2.47$2.16179,585 shs$9.93 million05/14/2024$2.16$2.17+0.46%$2.21$2.0838,348 shs$9.29 million05/13/2024$2.16$2.16$2.30$2.1234,546 shs$9.25 million05/10/2024$2.24$2.16-3.57%$2.24$2.1065,469 shs$9.24 million05/09/2024$2.27$2.24-1.32%$2.37$2.1530,558 shs$9.59 million05/08/2024$2.13$2.27+6.57%$2.48$2.10234,732 shs$9.72 million05/07/2024$2.01$2.13+5.97%$2.19$1.86134,752 shs$9.12 million05/06/2024$1.80$2.01+11.67%$2.08$1.672.13 million shs$8.60 million05/03/2024$1.80$1.80$1.84$1.803,705 shs$7.70 million05/02/2024$1.72$1.80+4.65%$1.92$1.7851,597 shs$7.70 million05/01/2024$1.74$1.72-1.18%$1.78$1.715,019 shs$7.36 million04/30/2024$1.66$1.74+4.85%$1.76$1.697,565 shs$7.45 million04/29/2024$1.69$1.66-1.78%$1.72$1.658,716 shs$7.11 million04/26/2024$1.67$1.69+1.50%$1.70$1.6016,331 shs$7.23 million04/25/2024$1.60$1.67+4.06%$1.67$1.525,262 shs$7.12 million04/24/2024$1.63$1.60-1.84%$1.64$1.558,444 shs$6.85 million04/23/2024$1.66$1.63-1.81%$1.68$1.6117,177 shs$6.98 million04/22/2024$1.63$1.66+1.84%$1.75$1.54199,170 shs$7.11 million04/19/2024$1.71$1.64-4.09%$1.77$1.6324,591 shs$7.02 million04/18/2024$1.77$1.71-3.12%$1.79$1.696,766 shs$7.32 million04/17/2024$1.75$1.77+0.86%$1.80$1.6727,840 shs$7.55 million04/16/2024$1.74$1.75+0.57%$1.86$1.747,102 shs$7.49 million04/15/2024$1.86$1.74-6.45%$1.93$1.7312,467 shs$7.45 million04/12/2024$1.87$1.86-0.53%$1.90$1.8024,362 shs$7.96 million04/11/2024$1.88$1.87-0.53%$1.91$1.7841,495 shs$8.00 million04/10/2024$1.87$1.88+0.53%$1.88$1.7312,831 shs$8.05 million04/09/2024$1.89$1.87-1.06%$1.91$1.844,375 shs$8.00 millionEverything from semiconductors to space shuttles depend on this overlooked mineral (Ad)Boron is also at the heart of a breakthrough that could fuel one of mankind's most sensational advances in semiconductor technologies. A critical next step to satisfy the massive processing needs of AI and quantum computing.Click here to learn how this overlooked mineral shapes the world today04/08/2024$1.88$1.89+0.53%$1.90$1.824,980 shs$8.09 million04/05/2024$1.92$1.88-1.83%$1.97$1.8325,001 shs$8.05 million04/04/2024$1.89$1.92+1.32%$1.97$1.8719,927 shs$8.20 million04/03/2024$1.87$1.89+1.07%$2.09$1.8543,525 shs$8.09 million04/02/2024$1.83$1.87+2.19%$1.87$1.828,318 shs$8.00 million04/01/2024$1.81$1.83+1.39%$1.85$1.7715,040 shs$7.83 million03/29/2024$1.81$1.81$1.85$1.7641,388 shs$7.73 million03/28/2024$1.85$1.81-2.43%$1.85$1.7641,388 shs$7.73 million03/27/2024$1.86$1.85-0.54%$1.87$1.7816,601 shs$7.92 million03/26/2024$1.92$1.86-3.12%$1.97$1.8024,274 shs$7.95 million03/25/2024$1.87$1.92+2.67%$1.96$1.8232,008 shs$8.22 million03/22/2024$1.82$1.87+2.75%$1.88$1.835,021 shs$8.00 million03/21/2024$1.86$1.82-2.15%$1.91$1.8214,311 shs$7.79 million03/20/2024$1.85$1.86+0.54%$1.87$1.7912,882 shs$7.96 million03/19/2024$1.72$1.85+7.56%$1.89$1.7165,111 shs$7.92 million03/18/2024$1.73$1.72-0.58%$1.76$1.6723,477 shs$7.36 million03/15/2024$1.64$1.73+5.49%$1.83$1.6356,193 shs$7.40 million03/14/2024$1.77$1.64-7.34%$1.85$1.6345,816 shs$7.02 million03/13/2024$1.79$1.77-0.84%$1.84$1.7610,508 shs$7.58 million03/12/2024$1.63$1.79+9.51%$1.88$1.6244,339 shs$7.63 million03/11/2024$1.69$1.63-3.55%$1.75$1.6043,228 shs$6.98 million03/08/2024$1.73$1.69-2.31%$1.76$1.6725,063 shs$7.23 million03/07/2024$1.94$1.73-10.59%$1.95$1.63177,175 shs$7.83 million03/06/2024$2.18$1.94-11.24%$2.26$1.9271,136 shs$8.75 million03/05/2024$2.13$2.18+2.35%$2.25$2.0455,347 shs$9.85 million03/04/2024$1.99$2.13+7.04%$2.18$1.9979,080 shs$9.63 million Related Companies: DarioHealth Stock Chart IceCure Medical Stock Chart Lucid Diagnostics Stock Chart Cytosorbents Stock Chart Daxor Stock Chart Beyond Air Stock Chart iCAD Stock Chart Autonomix Medical Stock Chart Modular Medical Stock Chart GBS Stock Chart Receive PSTV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PSTV) was last updated on 6/4/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyElon Musk’s Final Masterpiece: “X-9840”Paradigm PressAlert: Your Bank is Dying – Act Now or Lose Everything!Priority GoldDoes this make you sick?Allegiance GoldWas the Great Financial Crisis fun?Brooks EnterprisesEverything from semiconductors to space shuttles depend on this overlooked mineralCapital TrendsCollapse of the Petrodollar Colonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.